@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://purl.org/vocab/frbr/core#> .
@prefix ns2: <http://purl.org/spar/pro/> .
@prefix ns3: <http://purl.org/spar/datacite/> .
@prefix ns4: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<> dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/legalcode> .

<https://w3id.org/oc/meta/br/0640888756> a <http://purl.org/spar/fabio/Expression>,
        <http://purl.org/spar/fabio/JournalArticle> ;
    rdfs:label "br 0640888756" ;
    ns4:publicationDate "2015-05-08"^^xsd:date ;
    dcterms:title "Effects Of Bioisosteric Fluorine In Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, And STS-135" ;
    ns3:hasIdentifier <https://w3id.org/oc/meta/id/062504435359>,
        <https://w3id.org/oc/meta/id/0640937551>,
        <https://w3id.org/oc/meta/id/0672093550> ;
    ns2:isDocumentContextFor <https://w3id.org/oc/meta/ar/06403799360>,
        <https://w3id.org/oc/meta/ar/06403799361>,
        <https://w3id.org/oc/meta/ar/06403799362>,
        <https://w3id.org/oc/meta/ar/06403799363>,
        <https://w3id.org/oc/meta/ar/06403799364>,
        <https://w3id.org/oc/meta/ar/06403799365>,
        <https://w3id.org/oc/meta/ar/06403799366>,
        <https://w3id.org/oc/meta/ar/06403799367>,
        <https://w3id.org/oc/meta/ar/06403799368>,
        <https://w3id.org/oc/meta/ar/06403799369>,
        <https://w3id.org/oc/meta/ar/06403799370>,
        <https://w3id.org/oc/meta/ar/06403799371>,
        <https://w3id.org/oc/meta/ar/06403799372>,
        <https://w3id.org/oc/meta/ar/06403799373> ;
    ns1:embodiment <https://w3id.org/oc/meta/re/0640684849> ;
    ns1:partOf <https://w3id.org/oc/meta/br/0640889371> .